publication venue for
- Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy.. 19:155. 2024
- Stereotactic body radiotherapy for osseous low alpha–beta resistant metastases for pain relief—SOLAR-P. 16:170. 2021
- A pilot study of stereotactic boost for malignant epidural spinal cord compression: clinical significance and initial dosimetric evaluation. 15:267. 2020
- Indications, feasibility, safety, and efficacy of CyberKnife radiotherapy for the treatment of olfactory groove meningiomas: a single institutional retrospective series. 15:63. 2020
- Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors. 12:148. 2017
- Systematic review of patient reported quality of life following stereotactic ablative radiotherapy for primary and metastatic liver cancer. 12:110. 2017
- Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. 10:112. 2015
- A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases. 7:42. 2012
- Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts. 7:71. 2012
- Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. 6:144. 2011
- Spinal cord stimulators and radiotherapy: First case report and practice guidelines. 6:143. 2011